Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renee N Cottle

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Human Genetics|June 18, 2016
Treating hemoglobinopathies using gene-correction approaches: promises and challengesRenee N Cottle, Ciaran M Lee, Gang Bao
Scientific Reports|November 13, 2015
Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjectionRenee N Cottle, Ciaran M Lee, David Archer, et al.
Journal of Visualized Experiments : Jove|June 20, 2022
Electroporation-mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse HepatocytesTanner Rathbone, Ilayda Ates, Callie Stuart, et al.
The Yale Journal of Biology and Medicine|December 21, 2017
Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the LiverTaylor E Bryson, Caitlin M Anglin, P Hudson Bridges, et al.
Genes|September 26, 2020
Delivery Approaches for Therapeutic Genome Editing and ChallengesIlayda Ates, Tanner Rathbone, Callie Stuart, et al.
The CRISPR Journal|March 3, 2022
Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary HepatocytesTanner Rathbone, Ilayda Ates, Lawrence Fernando, et al.
The CRISPR Journal|April 3, 2026
Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the LiverJustin R Gibson, Abishek Dhungana, Menam Pokhrel, et al.
Frontiers in Medical Technology|January 20, 2022
<i>In vitro</i> Studies of Transendothelial Migration for Biological and Drug DiscoveryAlec T Salminen, Zahra Allahyari, Shayan Gholizadeh, et al.
Hepatology Communications|April 26, 2024
Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1Ilayda Ates, Callie Stuart, Tanner Rathbone, et al.
Biology|September 4, 2025
One Shock, Not One Cure: Electroporation Reveals Disease-Specific Constraints in Hepatocyte Gene Editing TherapyCallie Clark, Menam Pokhrel, Benjamin Arthur, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Human Genetics|June 18, 2016
Treating hemoglobinopathies using gene-correction approaches: promises and challengesRenee N Cottle, Ciaran M Lee, Gang Bao
Scientific Reports|November 13, 2015
Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjectionRenee N Cottle, Ciaran M Lee, David Archer, et al.
Journal of Visualized Experiments : Jove|June 20, 2022
Electroporation-mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse HepatocytesTanner Rathbone, Ilayda Ates, Callie Stuart, et al.
The Yale Journal of Biology and Medicine|December 21, 2017
Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the LiverTaylor E Bryson, Caitlin M Anglin, P Hudson Bridges, et al.
Genes|September 26, 2020
Delivery Approaches for Therapeutic Genome Editing and ChallengesIlayda Ates, Tanner Rathbone, Callie Stuart, et al.
The CRISPR Journal|March 3, 2022
Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary HepatocytesTanner Rathbone, Ilayda Ates, Lawrence Fernando, et al.
The CRISPR Journal|April 3, 2026
Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the LiverJustin R Gibson, Abishek Dhungana, Menam Pokhrel, et al.
Frontiers in Medical Technology|January 20, 2022
<i>In vitro</i> Studies of Transendothelial Migration for Biological and Drug DiscoveryAlec T Salminen, Zahra Allahyari, Shayan Gholizadeh, et al.
Hepatology Communications|April 26, 2024
Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1Ilayda Ates, Callie Stuart, Tanner Rathbone, et al.
Biology|September 4, 2025
One Shock, Not One Cure: Electroporation Reveals Disease-Specific Constraints in Hepatocyte Gene Editing TherapyCallie Clark, Menam Pokhrel, Benjamin Arthur, et al.
Pageof 1